Immunotherapy Toxicities: Checkpoint Inhibitors 0.75 CE

Immunotherapy Toxicities: Checkpoint Inhibitors

    Learning Objectives

    At the end of the presentation the learner will be able to:

    • Define the function of the immune system
    • Describe the type, mechanism of action, and indication for immunotherapy
    • Identify common and rare toxicities associated with checkpoint inhibitors
    • Recall methods of patient education surrounding immunotherapy toxicities

    Additional Information

    AttachmentSize
    PDF icon Activity Information Sheet.pdf32.09 KB
    Course summary
    Available credit: 
    • 0.75 ANCC
      UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
    Course opens: 
    12/08/2021
    Course expires: 
    12/08/2022
    Part of: 
    Oncology Nurse Education
    Enduring Education
    Pittsburgh, PA 15232
    United States

    Amy DiMaggio, MSN, RN, CMSRN, OCN

    In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    The maximum number of hours awarded for this Continuing Nursing Education activity is 0.75 contact hours.

    Available Credit

    • 0.75 ANCC
      UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
    Please login or register to take this course.